Did some calcs and some reading. Feel free to add or correct.
So... Vince sold Anacor to Pfizer for 5.2 billion $USD in Jun 2016, which was for an eczema gel that reached phase 3.
Taking a USD inflation calculator, this is 6.82 billion $USD in today's value.
If Vince meets this previous achievement (not even beat it right), noting we got 1.81 billion shares on issue, this is a SP of $3.77 USD or $5.61 AUD for BOT.
We don't have a phase 3 drug; we got better. We got an FDA approved drug. Imagine what that means for BOT's future.
BOT - Anything but charting, page-11144
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.015(4.05%) |
Mkt cap ! $699.7M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 37.0¢ | $1.537M | 4.028M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 91664 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |